Earlier detection. Smarter prevention.

A multimodal study by CHUV, EPFL and HUG bringing together cardiology, AI, and data science to identify the earliest signs of cardiovascular disease and pave the way for more personalized prevention.

Discover the study

Understand

the early mechanisms of cardiovascular disease

Integrate

advanced cardiovascular imaging, circulating biomarkers, and lifestyle data into a comprehensive approach

Prevent

cardiovascular events through personalized, data-driven strategies

Participants

SwissCardIA will follow 2,000 adults from the general population using a unique deep-phenotyping approach that combines cardiovascular imaging, biological data, clinical assessments and digital measures of lifestyle.

Discover the study population

Innovation

SwissCardIA is a next-generation research initiative at the intersection of clinical cardiology and data science, bringing together internationally recognized experts.

Discover our research

29.09.2026

Meeting the public on World Heart Day

On September 29th, several members of the SwissCardIA team took part in a public conference organised by the CHUV Cardiology Service to mark World Heart Day.

17.09.2026

IRB approval obtained for the SwissCardIA cohort study

The SwissCardIA cohort study protocol has received approval from both Institutional Review Boards of the two cantons where the study will take place, marking a major milestone towards the study's launch. This approval reflects our commitment to scientific excellence, participant safety, and the highest standards of research ethics and data protection.

15.05.2026

Behind the scenes of increasingly autonomous AI

Is artificial intelligence really beginning to reason? One of the SwissCardIA investigators, Prof. Emmanuel Abbé, works on the foundations of AI, complex networks, and how machines learn to make use of information.

22.03.2026

SwissCardIA receives a donation from the Fondation Michel Tossizza

The Fondation Michel Tossizza is providing CHF 100,000 in support to SwissCardIA, contributing to the funding of clinical equipment and connected devices used for longitudinal lifestyle monitoring.